Page last updated: 2024-10-28

hydralazine and Leukemia, Lymphoblastic, Acute, T Cell

hydralazine has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research Excerpts

ExcerptRelevanceReference
"Hydralazine treatment further resulted in the accumulation of reactive oxygen species, whereas a superoxide dismutase mimetic inhibited hydralazine-induced cell death."1.43The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells. ( Campillo-Davo, D; Lucendo, E; Martínez-Aguilar, R; Ruiz-Magaña, MJ; Ruiz-Ruiz, C; Schulze-Osthoff, K, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruiz-Magaña, MJ1
Martínez-Aguilar, R1
Lucendo, E1
Campillo-Davo, D1
Schulze-Osthoff, K1
Ruiz-Ruiz, C1

Other Studies

1 other study available for hydralazine and Leukemia, Lymphoblastic, Acute, T Cell

ArticleYear
The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells.
    Oncotarget, 2016, Apr-19, Volume: 7, Issue:16

    Topics: Antihypertensive Agents; Antineoplastic Agents; Apoptosis; DNA Damage; Humans; Hydralazine; Jurkat C

2016